HALOZYME THERAPEUTICS INC revenue breakdown overview

HALOZYME THERAPEUTICS INC revenue for the last year amounted to 980.78 M EUR, the most of which — 980.78 M EUR — came from its highest performing source at the moment, Enzymes and Devices, the year earlier bringing 751.31 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought HALOZYME THERAPEUTICS INC 666.97 M EUR, and the year before that — 532.01 M EUR.